Lawrence P. Carter - Concepedia

Author

Lawrence P. Carter

University of Arkansas for Medical Sciences ORCID

Also Known As

L.Philip Carter, Lawrence Carter, Lawrence P Carter, Lawrence P. Carter

Publications

Citations

H-Index

Concepts

All Affiliations

University of Arkansas for Medical Sciences Jazz Pharmaceuticals (United States)Johns Hopkins University Johns Hopkins Medicine Stanford Medicine

About

Lawrence P. Carter is an author at University of Arkansas for Medical Sciences specializing in medicine, social sciences, and psychopharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	539
2	Social Sciences	7	7	463
3	Anesthesia	2	2	60
4	Business	1	1	27
5	Health Sciences	1	1	20

Lawrence P. Carter

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
A randomized study of solriamfetol for excessive sleepiness in narcolepsy Michael J. Thorpy, Colin M. Shapiro, Geert Mayer, Annals of Neurology	2019	318
Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial Paula K. Schweitzer, Russell Rosenberg, Gary Zammit, American Journal of Respiratory and Critical Care Medicine	2018	305
Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy Hélène A. Emsellem, Michael J. Thorpy, Gert Jan Lammers, Sleep Medicine SleepFunctional OutcomesPsychiatryAddictionPsychotropic Medication	2019	191
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor Lawrence P. Carter, Jack E. Henningfield, Y Grace Wang, Journal of Psychopharmacology	2018	183
What would menthol smokers do if menthol in cigarettes were banned? Behavioral intentions and simulated demand Richard J. O’Connor, Maansi Bansal‐Travers, Lawrence P. Carter, Addiction	2012	95
Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB Lawrence P. Carter, Brian D. Richards, Miriam Z. Mintzer, Neuropsychopharmacology Substance AbusePsychoactive DrugPsychopathologySubstance UsePsychiatry	2006	95
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens Chad J. Reissig, Lawrence P. Carter, Matthew W. Johnson, Psychopharmacology Psychoactive DrugPharmacological StudyMedicineClub DrugPsychopharmacology	2012	88
Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor Michelle Baladi, Michael J. Forster, Michael B. Gatch, Journal of Pharmacology and Experimental Therapeutics	2018	86
Solriamfetol for the Treatment of Excessive Sleepiness in OSA Patrick Strollo, Jan Hedner, Nancy A. Collop, CHEST Journal	2018	80
Contributions of the parietal and frontal lobes to sustained attention and habituation Mark Mennemeier, Anjan Chatterjee, Robert T. Watson, Neuropsychologia Frontal LobesCognitive ScienceNeuropsychologyBrain FunctionBehavioral Neuroscience	1994	76

Page 1